Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleolin-mediated cancer diagnostics and therapy

Nucleolin-mediated cancer diagnostics and therapy

US Patent 11434288 · Granted Sep 6, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rare cell capture system and application thereof2024
Molecular design of recombinant protein drug2020
Endostatin mutants with mutations at ATP binding sites2020
Use of nucleolin as a biomarker for lymphangiogenesis in a cancer prognosis and 2018
Method of inhibiting or treating cancer metastasis2017
Methods and compositions for enhancing the uptake of therapeutic agents by targe2016
Application of fibrinogen-420 and its active domain2015
Method for cancer detection2015
Tumor biomarker2013
Methods of treating cancer using a modified endostatin protein2008
N-terminal modified recombinant human endostatin and its production2006